Brazil's President Lula, 79, in ICU After Emergency Brain Surgery to Drain Hemorrhage from October Fall
Dec 10, 2024, 08:37 AM
Brazilian President Luiz Inácio Lula da Silva, 79, underwent emergency brain surgery early Tuesday morning to drain an intracranial hemorrhage at the Sírio-Libanês hospital in São Paulo. After experiencing headaches in Brasília, he was admitted to the hospital where medical imaging revealed the bleeding, a consequence of a domestic accident on October 19. President Lula was transferred to São Paulo for the procedure, a craniotomy to remove a subdural hematoma, which was completed without complications. He is currently in the intensive care unit under observation and is reported to be in good condition.
View original story
Cabinet Minister • 25%
Other • 25%
Temporary Committee • 25%
Vice President • 25%
Cabinet Minister • 25%
Vice President Geraldo Alckmin • 25%
No change, Lula continues • 25%
Other • 25%
Minister of Economy • 25%
Minister of Justice • 25%
Vice President • 25%
Other government official • 25%
Minister of Institutional Relations Alexandre Padilha • 25%
Vice President Geraldo Alckmin • 25%
No Acting President Needed • 25%
Another Cabinet Member • 25%
No change • 25%
Vice President • 25%
Interim leader appointed • 25%
Cabinet member • 25%
Minister of Health • 25%
Vice President • 25%
Other • 25%
Minister of Justice • 25%
Vice President • 25%
No interim needed • 25%
Temporary Committee • 25%
Designated Cabinet Member • 25%
Other arrangement • 25%
No acting president appointed • 25%
Vice President appointed as acting president • 25%
Temporary committee formed • 25%
Vice President • 25%
Other • 25%
Minister of Finance • 25%
Minister of Justice • 25%
Vice President Geraldo Alckmin • 25%
No acting President appointed • 25%
Another government official • 25%
Other • 25%
Minister of Defense • 25%
Vice President • 25%
Other • 25%
Minister of Justice • 25%
No change • 25%
Interim Leader • 25%
Vice President • 25%
Cabinet Member • 25%
Other outcomes • 25%
Full recovery • 25%
Partial recovery with ongoing treatment • 25%
Significant health decline • 25%
Supportive • 25%
Mixed reactions • 25%
Indifferent • 25%
Critical • 25%